Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Up 7.6% in December

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a significant growth in short interest in December. As of December 15th, there was short interest totalling 9,900 shares, a growth of 7.6% from the November 30th total of 9,200 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily volume of 690,100 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on Check-Cap in a research report on Friday, December 27th. They issued a “sell” rating on the stock.

Check-Cap Stock Down 13.9 %

Shares of CHEK stock opened at $0.99 on Thursday. The stock has a market capitalization of $5.79 million, a PE ratio of -0.33 and a beta of 0.25. Check-Cap has a 52-week low of $0.56 and a 52-week high of $3.45. The stock’s 50-day moving average price is $0.94 and its 200 day moving average price is $1.51.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.